Combating Drug Abuse by Targeting Toll-Like Receptor 4 (TLR)
Abstract
This 3 year multi-site project is now complete. It has successfully studied the role of toll like receptor 4 in both opioid and cocaine reward / reinforcement. In addition it has successfully documented the potential of ( )naltrexone (a clinically relevant, blood brain barrier permeable, non-opioid toll like receptor 4antagonist) as an inhibitor of the rewarding / reinforcing effects of cocaine and opioids. Notably, it suppresses reinstatement to drug seeking (relapse)supportive of the interest in this compound for aiding drug abusers in the goal of avoiding relapse. In exploring brain mechanisms underlying these effects, we have accrued evidence supportive of both nucleus accumbens and ventral tegmental nucleus involvement.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2015
- Accession Number
- AD1007485
Entities
People
- Jonathan Katz
- Linda R. Watkins
- Ryan Bachtell
- Steven Maier
Organizations
- University of Colorado Boulder